LncRNA MIR9-3HG Enhances LIMK1 MRNA and Protein Levels to Contribute to the Carcinogenesis of Lung Squamous Cell Carcinoma Via Sponging MiR-138-5p and Recruiting TAF15
Overview
Affiliations
The aberrantly expressed long non-coding RNAs (lncRNAs) are closely correlated with the malignant progression of cancer cells. In our study, we identified lncRNA MIR9-3 host gene (MIR9-3HG) as the research target and explored its roles in lung squamous cell carcinoma (LUSC). RT-qPCR was conducted to reveal that MIR9-3HG was observably overexpressed in LUSC cells. Functional assays encompassing colony formation, 5-ethynyl-2'-deoxyuridine (EdU) staining, transwell and flow cytometry assays and western blot detecting related proteins demonstrated that MIR9-3HG depletion hampered cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) while accelerating cell apoptosis in LUSC. Subcellular fractionation assay were performed to demonstrate that MIR9-3HG was prominently distributed in the cytoplasm of LUSC cells. Luciferase reporter, RNA-binding protein immunoprecipitation (RIP), immunofluorescence (IF), fluorescent in situ hybridization (FISH) and RNA pull down assays were implemented to confirm that MIR9-3HG modulates LIM domain kinase 1 (LIMK1) mRNA and protein levels by sequestering microRNA-138-5p (miR-138-5p) and recruiting TATA-box binding protein associated factor 15 (TAF15) protein. Taken together, our research determined that MIR9-3HG up-regulated LIMK1 mRNA and protein levels to promote LUSC carcinogenesis, which offers a novel insight into mechanisms of LUSC.
Tata-box-binding protein-associated factor 15 as a new potential marker in gastrointestinal tumors.
Elpek G World J Gastroenterol. 2024; 30(28):3367-3372.
PMID: 39091718 PMC: 11290397. DOI: 10.3748/wjg.v30.i28.3367.
Guo Q, Zhang G, Zhou W, Lu Y, Chen X, Deng Z MedComm (2020). 2024; 5(6):e547.
PMID: 38764726 PMC: 11099756. DOI: 10.1002/mco2.547.
Braga E, Fridman M, Burdennyy A, Loginov V, Dmitriev A, Pronina I Int J Mol Sci. 2023; 24(17).
PMID: 37686426 PMC: 10487663. DOI: 10.3390/ijms241713617.
Huang J, Xu Z, Zhou C, Cheng L, Zeng H, Shen Y World J Surg Oncol. 2023; 21(1):180.
PMID: 37312123 PMC: 10265901. DOI: 10.1186/s12957-023-03067-w.
Guo C, Tang L, Li X, Huang L World J Gastroenterol. 2023; 29(19):2932-2949.
PMID: 37274797 PMC: 10237090. DOI: 10.3748/wjg.v29.i19.2932.